Dr. John Cush RheumNow
6 years 7 months ago
QD Clinic - Managing Comorbidities in Psoriatic Patients; whats the rheumatologists role? Watch it here>> https://t.co/vM1FxEceKu or listen to the podcast on iTunes or Soundcloud >> https://t.co/OEVuLUItZ9
QD Clinic - Managing Comorbidities in Psoriatic Patients
The Rheumatologists Role in Comorbidity Management
QD Clinic - Managing Comorbidities in Psoriatic Patients
The Rheumatologists Role in Comorbidity Management
QD Clinic - Managing Comorbidities in Psoriatic Patients
The Rheumatologists Role in Comorbidity Management
QD Clinic - Managing Comorbidities in Psoriatic Patients
The Rheumatologists Role in Comorbidity Management
Dr. John Cush RheumNow
6 years 7 months ago
QD Clinic - Chat 'em Up. The need for chit chat in the clinic. Watch it here>> https://t.co/vM1FxEceKu or listen to the podcast on iTunes or Soundcloud >> https://t.co/OEVuLUItZ9
An Italian study examined the outcomes in adult onset Still's disease (AOSD) based on whether they received early or delayed treatment with anakinra (ANK).
A total of 141 AOSD patients were retrospectively studied.
Overall, they found no differences in efficacy if ANK was started within 6 (or 12 mos) vs. thereafter.
While there are numerous agents approved for use in juvenile idiopathic arthritis, little is know about actual use biological disease-modifying antirheumatic drug (DMARD) use or switching in the biologic era. A cohort comparison study has shown that after an unsuccessful trial of a first biologic, changing to a second TNFi is as effective as switching to a non-TNFi biologic.
QD Clinic - Chat 'em Up
The Power of Conversation
Dr. John Cush RheumNow
6 years 7 months ago
TNF inhibitors may slow, but do not stop, Xray progression in AS, Anti–IL-17A agents may maybe the same. Study by Inman et al shows that Tyk2 inhibition may prevent xray damage (animal model) by blocking IL-23 signaling and IL-22 production. https://t.co/OyyKoqdCl9
Dr. John Cush RheumNow
6 years 7 months ago
Dr Alan Menter #UTSW Rheum Grand Rounds the cause of death in psoriasis is mostly cardiovascular https://t.co/PPQqO4rS5h
Dr. John Cush RheumNow
6 years 7 months ago
CORRONA study of 24,528 #RA pts; 32% also has Sjogrens syndrome (overall SS prevalence in RA = 0.30 ). SS more likely with increasing RA duration, older, female, seropositive; higher DZ activity; more comorbidities and extra-articular manifestations https://t.co/EgTSzKHmtL
Dr. John Cush RheumNow
6 years 7 months ago
193 #RA pts starting a TNFi followed for 12ms; 21.7% were non‐adherent to TNFi - No difference between different TNFi's. Predictors of nonadherence included High age, low DZ activity, ^^comorbidities, more injection site pain & Rxns https://t.co/qclzJiglMj
Dr. John Cush RheumNow
6 years 7 months ago
QD Clinic is up - this one is all thing leflunomide - Aravarama! Watch here>> https://t.co/UTHIA8mDPH or Listen to the podcast on iTunes or here>> https://t.co/bK2kmKfDOQ
Dr. John Cush RheumNow
6 years 7 months ago
Annals of Internal Medicine has a Full read REVIEW of FIBROMYALGIA https://t.co/4Ux6rqIkHo
